openPR Logo

Press Releases from Okairos (1 total)

Okairos Raises €16 Million in Series B Financing

Basel, Switzerland – September 14, 2010 – Okairos today announced the completion of a Series B private financing round totaling €16 million. The funds will be used to advance the company’s emerging portfolio of prophylactic and therapeutic vaccines against major life-threatening diseases through clinical proof of concept. The financing was led by Versant Ventures and joined by the Boehringer Ingelheim Venture Fund. All existing investors – BioMedPartners, LSP and

Go To Page:   1 2 3 4 5 6 7 8 9 10